Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data
The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
The pathogen Staphylococcus aureus uses various strategies for persisting in the host, among which switching to a small-colony variant (SCV) phenotype is of particular biological and therapeutic significance. Phenotypically, SCVs are characterized by a slow growth rate, atypical colony morphology and unusual biochemical features, constituting a real challenge for identification by the clinical microbiology laboratory. Their metabolic defects also alter their susceptibility to antibiotics, which, combined with the ability to survive intracellularly and, for some strains, to form biofilms, largely contributes to therapeutic failures. This paper reviews the available literature on antibiotic activity against SCVs of S. aureus in vitro, in animal models and in clinics. In vitro, aminoglycosides and antifolate agents show high MICs for electron-transport-defective and thymidine-dependent SCVs, respectively. The other antibiotic classes usually show MICs comparable to those measured for the parental strains, but they are less bactericidal. Intracellularly, auxotrophs for thymidine, haemin or menadione show contrasting behaviours with respect to their response to antibiotics, resulting from differences in their intracellular fate. In animal models, SCVs often persist in various locations, including metastatic ones, in spite of the administration of active antibiotics. In healthcare, several case reports mention the selection of SCVs after prolonged administration of not only aminoglycosides and antifolate agents, but also several other antibiotic classes. Apparent eradication requires several weeks or even months of aggressive polytherapy combined, whenever possible, with surgical intervention. Further research is thus warranted for optimizing the treatment of infections caused by SCVs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite the importance of these defenses for wild-type S. aureus survival in the host, SCVs have been reported to produce significantly reduced levels of staphyloxanthin and heme auxotrophs are deficient in catalase, which would be expected to make them more susceptible to ROS generated by neutrophils and thus clearance from host tissues (9, 19, 28, 36, 45).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [28]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Despite the importance of these defenses for wild-type S. aureus survival in the host, SCVs have been reported to produce significantly reduced levels of staphyloxanthin and heme auxotrophs are deficient in catalase, which would be expected to make them more susceptible to ROS generated by neutrophils and thus clearance from host tissues (9, 19, 28, 36, 45).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [28]
Experimental — accuracy not yet measuredIn the citing paper
“In addition to aminoglycoside resistance, SCVs that arise via the loss of the electron transport chain are more tolerant than wild-type bacteria of other classes of bactericidal antibiotics (8, 9, 25–29).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [28]
In the citing paper
“Despite the importance of these defenses for wild-type S. aureus survival in the host, SCVs have been reported to produce significantly reduced levels of staphyloxanthin and heme auxotrophs are deficient in catalase, which would be expected to make them more susceptible to ROS generated by neutrophils and thus clearance from host tissues (9, 19, 28, 36, 45).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., & Collins, J. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.049 · Cited by 2,982
Proctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
Self-citationTuchscherr, L., Medina, E., Hussain, M., Völker, W., Heitmann, V., Niemann, S., Holzinger, D., Roth, J., Proctor, R. A., Becker, K., et al. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201000115 · Cited by 437
Self-citationKahl, B., Herrmann, M., Everding, A. S., Koch, H. G., Becker, K., Harms, E., Proctor, R. A., & Peters, G. (1998) · Journal of Infectious Diseases · doi:10.1086/515238 · Cited by 357
Self-citationvon Eiff, C., Heilmann, C., Proctor, R. A., Woltz, C., Peters, G., & Götz, F. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.15.4706-4712.1997 · Cited by 310
Self-citationSingh, R., Ray, P., Das, A., & Sharma, M. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.009720-0 · Cited by 262
von Eiff, C., Bettin, D., Proctor, R. A., Rolauffs, B., Lindner, N., Winkelmann, W., & Peters, G. (1997) · Clinical Infectious Diseases · doi:10.1086/516962 · Cited by 247
Self-citationStaphylococcus aureus Small Colony Variants in Prosthetic Joint Infection
Sendi, P., Rohrbach, M., Graber, P., Frei, R., Ochsner, P. E., & Zimmerli, W. (2006) · Clinical Infectious Diseases · doi:10.1086/507633 · Cited by 232
Gao, W., Chua, K., Davies, J. K., Newton, H. J., Seemann, T., Harrison, P. F., Holmes, N. E., Rhee, H.-W., Hong, J.-I., Hartland, E. L., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000944 · Cited by 218
Prunier, A., Malbruny, B., Laurans, M., Brouard, J., Duhamel, J., & Leclercq, R. (2003) · The Journal of Infectious Diseases · doi:10.1086/374937 · Cited by 199
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria
Hall, C. W., & Mah, T.-F. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux010 · Cited by 1,696
Lebeaux, D., Ghigo, J.-M., & Beloin, C. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00013-14 · Cited by 1,318
Staphylococcal Osteomyelitis: Disease Progression, Treatment Challenges, and Future Directions
Kavanagh, N., Ryan, E. J., Widaa, A., Sexton, G., Fennell, J., O'Rourke, S., Cahill, K. C., Kearney, C. J., O'Brien, F. J., & Kerrigan, S. W. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00084-17 · Cited by 547
Nanocarriers for antibiotics: A promising solution to treat intracellular bacterial infections
Abed, N., & Couvreur, P. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.02.009 · Cited by 358
Biomaterials approaches to treating implant-associated osteomyelitis
Inzana, J. A., Schwarz, E. M., Kates, S. L., & Awad, H. A. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.12.012 · Cited by 333
Kahl, B. C., Becker, K., & Löffler, B. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00069-15 · Cited by 325
“Results on this subject were recently summarized in a review (130).”
BackgroundSelf-citationThe Continuing Threat of Methicillin-Resistant Staphylococcus aureus
Gajdács, M. (2019) · Antibiotics · doi:10.3390/antibiotics8020052 · Cited by 318
Prediction of antibiotic resistance: time for a new preclinical paradigm?
Sommer, M. O. A., Munck, C., Toft-Kehler, R. V., & Andersson, D. I. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.75 · Cited by 301
Antimicrobial Tolerance and Metabolic Adaptations in Microbial Biofilms
Crabbé, A., Jensen, P. Ø., Bjarnsholt, T., & Coenye, T. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.05.003 · Cited by 276
Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms
Hughes, D., & Andersson, D. I. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3922 · Cited by 245
Proctor, R. A., Kriegeskorte, A., Kahl, B. C., Becker, K., Löffler, B., & Peters, G. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00099 · Cited by 237
“Finally, persistence of S. aureus SCVs may also relate to the relative inefficiency of antibiotics to clear the organisms with host cells (Garcia et al., 2013).”
Self-citationEvolutionary Trajectories to Antibiotic Resistance
Hughes, D., & Andersson, D. I. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090816-093813 · Cited by 218
Chronic Implant-Related Bone Infections—Can Immune Modulation be a Therapeutic Strategy?
Seebach, E., & Kubatzky, K. F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01724 · Cited by 198
Ricciardi, B. F., Muthukrishnan, G., Masters, E., Ninomiya, M., Lee, C. C., & Schwarz, E. M. (2018) · Current Reviews in Musculoskeletal Medicine · doi:10.1007/s12178-018-9501-4 · Cited by 178
Dunyach-Remy, C., Ngba Essebe, C., Sotto, A., & Lavigne, J.-P. (2016) · Toxins · doi:10.3390/toxins8070209 · Cited by 168
“Indeed, they are relatively resistant to antibiotics [97,98] and, hence, difficult to eradicate with antibiotic therapy [99].”
Resistance Mechanisms to Antimicrobial Peptides in Gram-Positive Bacteria
Assoni, L., Milani, B., Carvalho, M. R., Nepomuceno, L. N., Waz, N. T., Guerra, M. E. S., Converso, T. R., & Darrieux, M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.593215 · Cited by 163
Impact of Staphylococcus aureus on Pathogenesis in Polymicrobial Infections
Nair, N., Biswas, R., Götz, F., & Biswas, L. (2014) · Infection and Immunity · doi:10.1128/iai.00059-14 · Cited by 155
Painter, K. L., Strange, E., Parkhill, J., Bamford, K. B., Armstrong-James, D., & Edwards, A. M. (2015) · Infection and Immunity · doi:10.1128/iai.03016-14 · Cited by 153
Virulence Factors in Coagulase-Negative Staphylococci
França, Â., Gaio, V., Lopes, N., & Melo, L. D. R. (2021) · Pathogens · doi:10.3390/pathogens10020170 · Cited by 182
Shettigar, K., & Murali, T. S. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03984-8 · Cited by 145
Tuchscherr, L., Löffler, B., & Proctor, R. A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01028 · Cited by 143
Self-citationIn vitro antimicrobial susceptibility testing methods: agar dilution to 3D tissue-engineered models
Schumacher, A., Vranken, T., Malhotra, A., Arts, J. J. C., & Habibović, P. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3089-2 · Cited by 180
Tuchscherr, L. P. N., Kreis, C., Hoerr, V., Flint, L., Hachmeister, M., Geraci, J., Bremer-Streck, S., Kiehntopf, M., Medina, E., Kribus, M., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv371 · Cited by 150
Guo, H., Tong, Y., Cheng, J., Abbas, Z., Li, Z., Wang, J., Zhou, Y., Si, D., & Zhang, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031241 · Cited by 120
Small colony variants (SCVs) of Staphylococcus aureus – A bacterial survival strategy
Kahl, B. C. (2014) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2013.05.016 · Cited by 118
Self-citationRadlinski, L. C., Rowe, S. E., Brzozowski, R., Wilkinson, A. D., Huang, R., Eswara, P. J., & Conlon, B. P. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.07.009 · Cited by 123
Zelmer, A. R., Nelson, R., Richter, K., & Atkins, G. J. (2022) · Bone Research · doi:10.1038/s41413-022-00227-8 · Cited by 142
Krezalek, M. A., Hyoju, S. K., Zaborin, A., Okafor, E., Chandrasekar, L., Bindokas, V., Guyton, K. L., Montgomery, C. P., Daum, R. S., Zaborina, O. Y., et al. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000002173 · Cited by 116
Tahaei, S. A. S., Stájer, A., Barrak, I., Ostorházi, E., Szabó, D., & Gajdács, M. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s303992 · Cited by 150
Therapeutic Potential of Antimicrobial Peptides in Polymicrobial Biofilm-Associated Infections
Batoni, G., Maisetta, G., & Esin, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020482 · Cited by 109
Aruldass, C. A., Louis, S. R., Venil, C. K., & Ahmad, W. A. (2017) · Environmental Science and Pollution Research · doi:10.1007/s11356-017-8855-2 · Cited by 92
A comprehensive review of bacterial osteomyelitis with emphasis on Staphylococcus aureus
Nasser, A., Azimi, T., Ostadmohammadi, S., & Ostadmohammadi, S. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104431 · Cited by 90
Infections in Patients with Cystic Fibrosis
Gilligan, P. H. (2014) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2014.02.001 · Cited by 90
“antimicrobials, especially b-lactams, because of their slow growth rate, making them more challenging to treat and resulting in a greater decline in pulmonary function.(17,19) The second resistance problem in patients with CF is the problem of methicillin-”
BackgroundDíaz-Pascual, F., Hartmann, R., Lempp, M., Vidakovic, L., Song, B., Jeckel, H., Thormann, K., Yildiz, F., Dunkel, J., Link, H., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0579-2 · Cited by 76
Leimer, N., Rachmühl, C., Palheiros Marques, M., Bahlmann, A. S., Furrer, A., Eichenseher, F., Seidl, K., Matt, U., Loessner, M. J., Schuepbach, R. A., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv388 · Cited by 81
Johani, K., Fritz, B. G., Bjarnsholt, T., Lipsky, B. A., Jensen, S. O., Yang, M., Dean, A., Hu, H., Vickery, K., & Malone, M. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.04.036 · Cited by 81
Respiration and Small Colony Variants of Staphylococcus aureus
Proctor, R. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0069-2019 · Cited by 78
Self-citationAntibiotic efficacy in the complex infection environment
Radlinski, L. C., & Conlon, B. P. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.09.007 · Cited by 86
Staphylococcus aureus strategies to evade the host acquired immune response
Goldmann, O., & Medina, E. (2018) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2017.09.013 · Cited by 76
Lerche, C. J., Schwartz, F. A., Theut, A. M., Fosbøl, E. L., Iversen, K. K., Bundgaard, H., Høiby, N., & Moser, C. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.643335 · Cited by 88
Dean, M. A., Olsen, R. J., Long, S. W., Rosato, A. E., & Musser, J. M. (2014) · Infection and Immunity · doi:10.1128/iai.01487-13 · Cited by 69
Küehl, R., Morata, L., Meylan, S., Mensa, J., & Soriano, À. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz559 · Cited by 73
Sharafutdinov, I., Trizna, E. Y., Baidamshina, D. R., Ryzhikova, M. N., Zamalieva, R. R., Мунавировна, Х. А., Зиннуровна, Л. Л., Рафаэловна, К. А., Rozhina, E. V., Klinger-Strobel, M., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02246 · Cited by 64
“There are only few antibiotics with specific mechanisms of action, which show some activity in S. aureus biofilms, e.g., rifampin and to a lesser extent daptomycin or fluoroquinolones (Garcia et al., 2013; Siala et al., 2014; Stein et al., 2016).”
Richter, K., Thomas, N., Zhang, G., Prestidge, C. A., Coenye, T., Wormald, P., & Vreugde, S. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00280 · Cited by 64
“The higher efficacy of the triple combinations Def-GaPP-Cip and Def-GaPP-Gent might rely on the synergy between reactive oxygen species (resulting from the Def-GaPP treatment) and antibiotics, as described elsewhere (Garcia L. G. et al., 2012; Garcia et al., 2013).”
BackgroundMethodInfluentialDalhoff, A. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00022-14 · Cited by 62
Gläser, R., Becker, K., von Eiff, C., Meyer‐Hoffert, U., & Harder, J. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.176 · Cited by 64
Self-citationAdvances in the local and targeted delivery of anti-infective agents for management of osteomyelitis
Ford, C. A., & Cassat, J. E. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1372192 · Cited by 59
Antimicrobial resistance three ways: healthcare crisis, major concepts and the relevance of biofilms
Jorge, P., Magalhães, A. P., Grainha, T., Alves, D. F., Sousa, A. M., Lopes, S. P., & Pereira, M. O. (2019) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiz115 · Cited by 67
Boonsiri, T., Watanabe, S., Tan, X.-E., Thitiananpakorn, K., Narimatsu, R., Sasaki, K., Takenouchi, R., Sato’o, Y., Aiba, Y., Kiga, K., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-73796-5 · Cited by 64
Lee, J., Zilm, P. S., & Kidd, S. P. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00321 · Cited by 51
Guay, I., Boulanger, S., Isabelle, C., Brouillette, É., Chagnon, F., Bouarab, K., Marsault, É., & Malouin, F. (2018) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-018-0197-2 · Cited by 55
Windolf, C. D., Lögters, T. T., Scholz, M., Windolf, J., & Flohé, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115940 · Cited by 50
Bogut, A., Niedźwiadek, J., Kozioł-Montewka, M., Strzelec-Nowak, D., Blacha, J., Mazurkiewicz, T., Marczyński, W. J., & Plewik, D. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.066068-0 · Cited by 50
Painter, K. L., Hall, A., Ha, K. P., & Edwards, A. M. (2017) · Infection and Immunity · doi:10.1128/iai.00659-17 · Cited by 51
Tkhilaishvili, T., Wang, L., Perka, C., Trampuž, A., & Moreno, M. G. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00695 · Cited by 49
Vestweber, P. K., Wächter, J., Planz, V., Jung, N., & Windbergs, M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304491 · Cited by 59
Trombetta, R. P., Dunman, P. M., Schwarz, E. M., Kates, S. L., & Awad, H. A. (2018) · mSphere · doi:10.1128/msphere.00422-18 · Cited by 48
Tan, N. C.-W., Cooksley, C. M., Roscioli, E., Drilling, A., Douglas, R. G., Wormald, P. J., & Vreugde, S. (2014) · Allergy · doi:10.1111/all.12457 · Cited by 48
Effects of colistin on biofilm matrices of Escherichia coli and Staphylococcus aureus
Klinger-Strobel, M., Stein, C., Forstner, C., Makarewicz, O., & Pletz, M. W. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.01.005 · Cited by 48
Abad, L., Dyon-Tafani, V., Tasse, J., Josse, J., Chidiac, C., Lustıg, S., Ferry, T., Diot, A., Laurent, F. J., & Valour, F. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky473 · Cited by 40
Ueda, Y., Mashima, K., Miyazaki, M., Hara, S., Takata, T., Kamimura, H., Takagi, S., & Jimi, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-39997-3 · Cited by 47
Intracellular Pharmacokinetics of Antibacterials and Their Clinical Implications
Pea, F. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0572-y · Cited by 43
“and this is consistent both with the reduced intracellular accumulation and with the lower in vitro activity exhibited by these antibacterial agents against intracellular SCVs [65].”
InfluentialGarcia-Moreno, M., Jordan, P. M., Günther, K., Dau, T., Fritzsch, C., Vermes, M., Schoppa, A., Ignatius, A. A., Wildemann, B., Werz, O., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.937466 · Cited by 40
Frenzel, E., Kranzler, M., Stark, T. D., Hofmann, T. F., & Ehling‐Schulz, M. (2015) · mBio · doi:10.1128/mbio.01172-15 · Cited by 42
Zheng, X., Fang, R., Wang, C., Tian, X., Lin, J., Zeng, W., Zhou, T., & Xu, C. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s301863 · Cited by 43
Trombetta, R. P., Ninomiya, M. J., El-Atawneh, I. M., Knapp, E. K., Bentley, K. L. D. M., Dunman, P. M., Schwarz, E. M., Kates, S. L., & Awad, H. A. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020094 · Cited by 39
Abad, L., Josse, J., Tasse, J., Lustıg, S., Ferry, T., Diot, A., Laurent, F. J., & Valour, F. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa061 · Cited by 44
Magalhães, A. P., Jorge, P., & Pereira, M. O. (2019) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2019.1700209 · Cited by 42
Bryson, D., Hettle, A. G., Boraston, A. B., & Hobbs, J. K. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02103-19 · Cited by 35
Siegmund, A., Afzal, M. A., Tetzlaff, F., Keinhörster, D., Gratani, F. L., Paprotka, K., Westermann, M., Nietzsche, S., Wolz, C., Fraunholz, M. J., et al. (2021) · Virulence · doi:10.1080/21505594.2021.1910455 · Cited by 44
Matarlo, J. S., Lü, Y., Daryaee, F., Daryaee, T., Ruzsicska, B. P., Walker, S. G., & Tonge, P. J. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00023 · Cited by 38
Iglesias, Y. D., Wilms, T., Vanbever, R., & Bambeke, F. V. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00602-19 · Cited by 40
A comprehensive review of pathology and treatment of staphylococcus aureus osteomyelitis
Song, M., Sun, J., Lv, K., Li, J., Shi, J., & Xu, Y. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01595-1 · Cited by 42
The Effects of Silver Sulfadiazine on Methicillin-Resistant Staphylococcus aureus Biofilms
Ueda, Y., Miyazaki, M., Mashima, K., Takagi, S., Hara, S., Kamimura, H., & Jimi, S. (2020) · Microorganisms · doi:10.3390/microorganisms8101551 · Cited by 40
Update on the challenging role of biofilms in peritoneal dialysis
Martins, M. I. B. C., Rodrigues, A. S., Pedrosa, J., Carvalho, M. J., Cabrita, A., & Oliveira, R. (2013) · Biofouling · doi:10.1080/08927014.2013.824566 · Cited by 37
A Network Biology Approach to Decipher Stress Response in Bacteria Using Escherichia coli As a Model
Nagar, S. D., Aggarwal, B., Joon, S., Bhatnagar, R., & Bhatnagar, S. (2016) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2016.0028 · Cited by 35
“The Small Colony Variant (SCV) in Staphylococcus aureus displays antibiotic resistance (Garcia et al., 2013; McNamara and Proctor, 2000) and is an adaptive mechanism for survival against environmental stress (Moisan et al., 2006) and intracellular factors (Schroder et al., 2006; Sendi and Proctor,…”
BackgroundBogut, A., & Magryś, A. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04315-1 · Cited by 33
Sultan, A. R., Tavakol, M., Toom, N. A. L.-D., Croughs, P. D., Verkaik, N. J., Verbon, A., & van Wamel, W. J. B. (2022) · PLoS ONE · doi:10.1371/journal.pone.0260272 · Cited by 29
Lenhard, J. R., von Eiff, C., Hong, I. S., Holden, P. N., Bear, M. D., Suen, A., Bulman, Z. P., & Tsuji, B. T. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04508-14 · Cited by 31
Giacomini, D., Torricelli, P., Gentilomi, G. A., Boanini, E., Gazzano, M., Bonvicini, F., Benetti, E., Soldati, R., Martelli, G., Rubini, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02943-2 · Cited by 26
Hachicho, N., Birnbaum, A., & Heipieper, H. J. (2017) · AMB Express · doi:10.1186/s13568-017-0371-8 · Cited by 29
Curtis, T. D., Gram, L., & Knudsen, G. M. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01056 · Cited by 27
Schniederjans, M., Koska, M., & Häußler, S. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01178-17 · Cited by 23
Morelli, P., Alessandri, A. D., Manno, G., Marchese, A. E., Bassi, M., Lobello, R., Minicucci, L., & Bandettini, R. (2015) · PubMed · Cited by 28
Chen, H., Wang, Q., Yin, Y., Li, S., Niu, D., & Wang, H. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.12.006 · Cited by 24
Becker, K. (2023) · Antibiotics · doi:10.3390/antibiotics12091446 · Cited by 30
Self-citationMonitoring local delivery of vancomycin from gelatin nanospheres in zebrafish larvae
Zhang, X., Song, J., Klymov, A., Zhang, Y., de Boer, L., Jansen, J. A., van den Beucken, J. J. J. P., Yang, F., Zaat, S. A. J., & Leeuwenburgh, S. C. G. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s168959 · Cited by 23
“…antibiotic delivery system may improve the efficacy of antibiotic delivery to eradicate intracellular staphylococci, possibly even antibiotic-tolerant bacterial phenotypes such as small colony variants of S. aureus 55 or other intracellular pathogens such as Mycobacterium tuberculosis .”
Cu-Doped Hollow Bioactive Glass Nanoparticles for Bone Infection Treatment
Jiménez‐Holguín, J., Sánchez‐Salcedo, S., Cicuéndez, M., Vallet‐Regí, M., & Salinas, A. J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040845 · Cited by 23
Small-Colony Variants in Persistent and Recurrent Staphylococcus aureus Bacteremia
Kim, K.-H., Kang, Y. M., Han, W. D., Park, K. U., Park, K., Yoo, J. I., Lee, D., Park, C., Song, K., Kim, E. S., et al. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2015.0262 · Cited by 28
“30,32,39 A recent study showed that SCV subpopulations emerge and expand during exponential growth of S. aureus by phenotype switching in a natural process that does not require any selective pressure, and that further expansion of the SCV populations occurs during growth under selective conditions.”
InfluentialVolk, C. F., Proctor, R. A., & Rose, W. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126486 · Cited by 23
“Combination therapy may be necessary to enhance bacterial clearance and prevent the emergence of resistance, but the optimal combination for SCV treatment is not established [47,48].”
BackgroundInfluentialSelf-citationColquhoun, J. M., Wozniak, R. A. F., & Dunman, P. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143033 · Cited by 22
Chen, C., Huang, Y., & Shie, S. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01414 · Cited by 24
Finafloxacin for the treatment of urinary tract infections
Bartoletti, R., Cai, T., Perletti, G., Wagenlehner, F. R. A., & Johansen, T. E. B. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1052401 · Cited by 20
Batko, I. Z., Flannagan, R. S., Guariglia-Oropeza, V., Sheldon, J. R., & Heinrichs, D. E. (2021) · Journal of Bacteriology · doi:10.1128/jb.00458-21 · Cited by 19
Schleimer, N., Kaspar, U., Knaack, D., von Eiff, C., Molinaro, S., Grallert, H., Idelevich, E. A., & Becker, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030716 · Cited by 19
Self-citationAnand, R., Moss, R. B., Sass, G., Banaei, N., Clemons, K. V., Martinez, M., & Stevens, D. A. (2017) · Mycopathologia · doi:10.1007/s11046-017-0186-9 · Cited by 21
Antibacterial Mechanisms and Clinical Impact of Sitafloxacin
Kuhn, E. M. A., Sominsky, L. A., Chittò, M., Schwarz, E. M., & Moriarty, T. F. (2024) · Pharmaceuticals · doi:10.3390/ph17111537 · Cited by 18
Cryptic resistance in Staphylococcus aureus: a risk for the treatment of skin infection?
Saeed, K. B. A., Marsh, P., & Ahmad, N. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000046 · Cited by 23
Krute, C. N., Carroll, R. K., Rivera, F. E., Weiss, A., Young, R. M., Shilling, A., Botlani, M., Varma, S., Baker, B. J., & Shaw, L. N. (2015) · Molecular Microbiology · doi:10.1111/mmi.12900 · Cited by 17
“Interestingly, ispA mutants also display classical hallmarks of S. aureus SCVs, including smaller colony size, a lack of pigmentation and impaired growth (Looney, 2000; Melter and Radojevic, 2010; Atalla et al., 2011; Day, 2013; Garcia et al., 2013).”
Metadata
- Authors
- Garcia, L. G., Lemaire, S., Kahl, B. C., Becker, K., Proctor, R. A., Denis, O., Tulkens, P. M., & Van Bambeke, F.
- Affiliations
- UCLouvain (BE)
- University Hospital Münster (DE)
- University of Wisconsin–Madison (US)
- Université Libre de Bruxelles (BE)
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-03-13
- Volume
- 68
- Issue
- 7
- Pages
- 1455-1464
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2096404632
- Cited by
- 177
- References
- 70
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 9 · 2023: 5 · 2022: 11 · 2021: 16 · 2020: 14 · 2019: 24 · 2018: 9 · 2017: 27 · 2016: 10 · 2015: 13 · 2014: 18 · 2013: 5
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- DIAL (Catholic University of Leuven) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Fonds De La Recherche Scientifique - FNRS (3.4530.12)
- Fonds pour la Formation à la Recherche dans l’Industrie et dans l’Agriculture
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- Staphylococcus aureus, small colony variants, antibiotic susceptibility, aminoglycosides, antifolate, intracellular survival, biofilm, antibiotic resistance, persistent infection, polypharmacy, thymidine auxotrophy
- MeSH terms
- Animals, Anti-Bacterial Agents, Humans, Microbial Sensitivity Tests, Phenotype, Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.